v3.26.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Summary of Segment Reporting
The table below summarizes the significant expense categories regularly reviewed by the CODM for the three months ended March 31, 2026 and 2025:
 
         
 

Three months ended
March 31
 
   
2026
   
2025
 
Revenue
 $2,403   $1,904 
Gross Profit
  1,684    1,067 
Gross profit %
  70.1%   56.0%
Operating expenses:
         
General and administrative
  2,371    1,846 
Sales and marketing
  2,084    1,430 
Development
  1,397    206 
Clinical, Quality, Regulatory
  400    578 
Total operating expenses
  6,252    4,060 
Stock Based Compensation
   -     67 
Other income (expense)
  (27   (46
Net income (loss)
 $(4,541  $(3,014